Published in Mol Endocrinol on September 01, 2001
Vitamin D and human health: lessons from vitamin D receptor null mice. Endocr Rev (2008) 5.28
Alternatively spliced isoforms of the human constitutive androstane receptor. Nucleic Acids Res (2003) 1.30
A novel polymorphism in the 1A promoter region of the vitamin D receptor is associated with altered susceptibilty and prognosis in malignant melanoma. Br J Cancer (2004) 1.13
Molecular link between vitamin D and cancer prevention. Nutrients (2013) 1.10
DNA methylation-related vitamin D receptor insensitivity in breast cancer. Cancer Biol Ther (2010) 1.02
Human male gamete endocrinology: 1alpha, 25-dihydroxyvitamin D3 (1,25(OH)2D3) regulates different aspects of human sperm biology and metabolism. Reprod Biol Endocrinol (2009) 0.87
Altered localization of retinoid X receptor alpha coincides with loss of retinoid responsiveness in human breast cancer MDA-MB-231 cells. Mol Cell Biol (2004) 0.86
Intron 4 containing novel GABAB1 isoforms impair GABAB receptor function. PLoS One (2010) 0.85
Mouse and human BAC transgenes recapitulate tissue-specific expression of the vitamin D receptor in mice and rescue the VDR-null phenotype. Endocrinology (2014) 0.85
Vitamin D receptor gene (VDR) transcripts in bone, cartilage, muscles and blood and microarray analysis of vitamin D responsive genes expression in paravertebral muscles of juvenile and adolescent idiopathic scoliosis patients. BMC Musculoskelet Disord (2012) 0.85
Nucleo-cytoplasmic cycling of the vitamin D receptor in the enterocyte-like cell line, Caco-2. J Cell Biochem (2007) 0.84
Perspectives of differentiation therapies of acute myeloid leukemia: the search for the molecular basis of patients' variable responses to 1,25-dihydroxyvitamin d and vitamin d analogs. Front Oncol (2014) 0.81
FRAP analysis of nucleocytoplasmic dynamics of the vitamin D receptor splice variant VDRB1: preferential targeting to nuclear speckles. Biochem J (2005) 0.79
Bryostatin-1, Fenretinide and 1α,25 (OH)(2)D(3) Induce Growth Inhibition, Apoptosis and Differentiation in T and B Cell-Derived Acute Lymphoblastic Leukemia Cell Lines (CCRF-CEM and Nalm-6). Avicenna J Med Biotechnol (2011) 0.79
Conserved steroid hormone homology converges on nuclear factor κB to modulate inflammation in asthma. J Investig Med (2012) 0.78
Vitamin D decreases STAT phosphorylation and inflammatory cytokine output in T-LGL Leukemia. Cancer Biol Ther (2016) 0.76
Inhibition of Methicillin-resistant Staphylococcus aureus-induced cytokines mRNA production in human bone marrow derived mesenchymal stem cells by 1,25-dihydroxyvitamin D3. BMC Cell Biol (2014) 0.75
Fine tuning of vitamin D receptor (VDR) activity by post-transcriptional and post-translational modifications. Oncotarget (2017) 0.75
Mortality after all major types of osteoporotic fracture in men and women: an observational study. Lancet (1999) 7.14
The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women. Osteoporos Int (2007) 6.44
Body mass index as a predictor of fracture risk: a meta-analysis. Osteoporos Int (2005) 5.54
Global vitamin D status and determinants of hypovitaminosis D. Osteoporos Int (2009) 5.43
Prediction of bone density from vitamin D receptor alleles. Nature (1994) 5.36
Familial susceptibility to still births and neonatal deaths. Am J Hyg (1939) 4.09
Vitamin-D-receptor-gene polymorphisms and change in lumbar-spine bone mineral density. Lancet (1995) 3.82
Genetic determinants of bone mass in adults. A twin study. J Clin Invest (1987) 3.23
Mobilization of lead from the skeleton during the postnatal period is larger than during pregnancy. J Lab Clin Med (1998) 3.18
Smoking and fracture risk: a meta-analysis. Osteoporos Int (2004) 3.08
Construction of an infectious molecular clone of the autonomous parvovirus minute virus of mice. J Virol (1983) 2.95
Lymphoid development in mice congenitally lacking T cell receptor alpha beta-expressing cells. Science (1992) 2.90
DNA sequence of the lymphotropic variant of minute virus of mice, MVM(i), and comparison with the DNA sequence of the fibrotropic prototype strain. J Virol (1986) 2.89
Prognosis of fracture: evaluation of predictive accuracy of the FRAX algorithm and Garvan nomogram. Osteoporos Int (2009) 2.63
A sensitive, precise, and convenient method for determination of 1,25-dihydroxyvitamin D in human plasma. Arch Biochem Biophys (1976) 2.23
Contribution of trans-acting factor alleles to normal physiological variability: vitamin D receptor gene polymorphism and circulating osteocalcin. Proc Natl Acad Sci U S A (1992) 2.20
Purification and characterization of human RNPS1: a general activator of pre-mRNA splicing. EMBO J (1999) 2.20
Osteopenia in HIV-infected men: association with asymptomatic lactic acidemia and lower weight pre-antiretroviral therapy. AIDS (2001) 2.17
A family history of fracture and fracture risk: a meta-analysis. Bone (2004) 2.13
Screening for osteoporosis: what is the role of heel ultrasound? Med J Aust (1996) 2.01
Symptomatic fracture incidence in elderly men and women: the Dubbo Osteoporosis Epidemiology Study (DOES). Osteoporos Int (1994) 1.95
1,25-dihydroxyvitamin D-responsive element and glucocorticoid repression in the osteocalcin gene. Science (1989) 1.88
Models of care for the secondary prevention of osteoporotic fractures: a systematic review and meta-analysis. Osteoporos Int (2012) 1.80
Risk factors for proximal humerus, forearm, and wrist fractures in elderly men and women: the Dubbo Osteoporosis Epidemiology Study. Am J Epidemiol (2001) 1.78
Deterioration in quality of life following hip fracture: a prospective study. Osteoporos Int (2000) 1.77
Bone mass, lean mass, and fat mass: same genes or same environments? Am J Epidemiol (1998) 1.74
Determinants of axial bone loss in rheumatoid arthritis. Arthritis Rheum (1987) 1.73
Osteoporosis in elderly men and women: effects of dietary calcium, physical activity, and body mass index. J Bone Miner Res (2000) 1.73
Risk factors for osteoporotic fractures in elderly men. Am J Epidemiol (1996) 1.70
Cost-effectiveness of Denosumab for the treatment of postmenopausal osteoporosis. Osteoporos Int (2010) 1.69
Development of prognostic nomograms for individualizing 5-year and 10-year fracture risks. Osteoporos Int (2008) 1.68
Vitamin D receptor alleles, bone mineral density and turnover in premenopausal Japanese women. J Bone Miner Res (1996) 1.67
Suppression of in vivo growth of human cancer solid tumor xenografts by 1,25-dihydroxyvitamin D3. Cancer Res (1987) 1.64
Physical fitness is a major determinant of femoral neck and lumbar spine bone mineral density. J Clin Invest (1986) 1.63
Osteoporosis in rheumatoid arthritis: safety of low dose corticosteroids. Ann Rheum Dis (1986) 1.62
p21-activated kinase (PAK1) is phosphorylated and activated by 3-phosphoinositide-dependent kinase-1 (PDK1). J Biol Chem (2000) 1.61
Bone density of élite female athletes with stress fractures. Med J Aust (1990) 1.52
Progressive loss of bone in the femoral neck in elderly people: longitudinal findings from the Dubbo osteoporosis epidemiology study. BMJ (1994) 1.51
A simple method for assessing calcium intake in Caucasian women. J Am Diet Assoc (1989) 1.46
Changing RANKL/OPG mRNA expression in differentiating murine primary osteoblasts. J Endocrinol (2001) 1.46
Osteoporosis prevention and treatment. Med J Aust (2000) 1.41
OsteoPPPorosis--prevention, prevention and prevention. Aust N Z J Med (1991) 1.39
Bone loss, physical activity, and weight change in elderly women: the Dubbo Osteoporosis Epidemiology Study. J Bone Miner Res (1998) 1.37
Multiple promoters direct the tissue-specific expression of novel N-terminal variant human vitamin D receptor gene transcripts. Proc Natl Acad Sci U S A (1998) 1.33
Dietary intake and bone mineral density. Bone Miner (1988) 1.31
Inhibition of human cancer cell growth by 1,25-dihydroxyvitamin D3 metabolites. Cancer Res (1983) 1.31
Visualizing levels of osteoblast differentiation by a two-color promoter-GFP strategy: Type I collagen-GFPcyan and osteocalcin-GFPtpz. Genesis (2005) 1.31
Sex hormone status and osteoporosis in postmenopausal women with rheumatoid arthritis. Arthritis Rheum (1988) 1.31
The use of multiple sites for the diagnosis of osteoporosis. Osteoporos Int (2006) 1.31
Odanacatib for the treatment of postmenopausal osteoporosis: development history and design and participant characteristics of LOFT, the Long-Term Odanacatib Fracture Trial. Osteoporos Int (2014) 1.29
1,25-Dihydroxyvitamin D in biological fluids: a simplified and sensitive assay. Science (1976) 1.26
Hormonal and biochemical parameters in the determination of osteoporosis in elderly men. J Clin Endocrinol Metab (1999) 1.25
Osteoporosis in young adults: pathophysiology, diagnosis, and management. Osteoporos Int (2012) 1.25
Direct clinical and welfare costs of osteoporotic fractures in elderly men and women. Osteoporos Int (1995) 1.24
1,25-dihydroxyvitamin-D-receptor in breast cancer cells. Lancet (1980) 1.22
Development of a nomogram for individualizing hip fracture risk in men and women. Osteoporos Int (2007) 1.22
A longitudinal study of the effect of spinal degenerative disease on bone density in the elderly. J Rheumatol (1995) 1.22
Genetic epidemiological approaches to the search for osteoporosis genes. J Bone Miner Res (2000) 1.19
Hormonal and biochemical parameters and osteoporotic fractures in elderly men. J Bone Miner Res (2000) 1.18
The contribution of vitamin D receptor gene alleles to the determination of bone mineral density in normal and osteoporotic women. J Bone Miner Res (1995) 1.18
Ski-interacting protein interacts with Smad proteins to augment transforming growth factor-beta-dependent transcription. J Biol Chem (2001) 1.17
Osteoarthritis, bone density, postural stability, and osteoporotic fractures: a population based study. J Rheumatol (1995) 1.15
Vitamin D receptor gene alleles and osteoporosis: an affirmative view. J Bone Miner Res (1995) 1.14
Effect of guanyl nucleotides on parathyroid hormone-responsive adenylate cyclase in chick kidney. J Endocrinol (1976) 1.10
Postural stability, falls and fractures in the elderly: results from the Dubbo Osteoporosis Epidemiology Study. Med J Aust (1994) 1.09
Association between breast cancer and bone mineral density: the Dubbo Osteoporosis Epidemiology Study. Maturitas (2000) 1.09
Sources of variability in bone mineral density measurements: implications for study design and analysis of bone loss. J Bone Miner Res (1997) 1.09
Receptors for 1,25(OH)2-vitamin D3 enriched in cloned osteoblast-like rat osteogenic sarcoma cells. FEBS Lett (1980) 1.08
Prevalent vertebral deformities: relationship to bone mineral density and spinal osteophytosis in elderly men and women. Osteoporos Int (1996) 1.08
A randomized study of two different information-based interventions on the management of osteoporosis in minimal and moderate trauma fractures. Osteoporos Int (2006) 1.07
The BsmI vitamin D receptor restriction fragment length polymorphism (bb) influences the effect of calcium intake on bone mineral density. J Bone Miner Res (1997) 1.07
Calcitonin and 1,25-dihydroxyvitamin D3 receptors in human breast cancer cell lines. Cancer Res (1980) 1.06
Quality of life in osteoporosis: reliability, consistency, and validity of the Osteoporosis Assessment Questionnaire. J Rheumatol (1998) 1.06
Genetic factors in bone turnover. J Clin Endocrinol Metab (1991) 1.05
Effects of low dose corticosteroids on bone mass in rheumatoid arthritis: a longitudinal study. Ann Rheum Dis (1989) 1.05
Intestinal cytosol binders of 1,25-dihydroxyvitamin D and 25-hydroxyvitamin D. Arch Biochem Biophys (1976) 1.05
Vitamin D status and parathyroid hormone in a urban population in Vietnam. Osteoporos Int (2010) 1.05
Sorting of tropomyosin isoforms in synchronised NIH 3T3 fibroblasts: evidence for distinct microfilament populations. Cell Motil Cytoskeleton (2000) 1.04
Femoral neck axis length, height loss and risk of hip fracture in males and females. Osteoporos Int (1998) 1.04
Increased growth after long-term oral 1alpha,25-vitamin D3 in childhood renal osteodystrophy. N Engl J Med (1978) 1.04
Determination of 25-hydroxyvitamin D2 and 25-hydroxyvitamin D3 in human plasma using high-pressure liquid chromatography. Anal Biochem (1977) 1.03
Thiazide diuretics and fractures: can meta-analysis help? J Bone Miner Res (1995) 1.03
Effects of estrogen exposure and reproductive factors on bone mineral density and osteoporotic fractures. J Clin Endocrinol Metab (1995) 1.03
Intestinal 1,25-dihydroxyvitamin D3 binding protein: specificity of binding. Steroids (1977) 1.02
Risk factors for vitamin D inadequacy among women with osteoporosis: an international epidemiological study. Int J Clin Pract (2006) 1.02
Recovery from steroid-induced osteoporosis. Ann Intern Med (1987) 1.01
Computer modeling and analysis of cross-sectional bone density studies with respect to age and the menopause. J Bone Miner Res (1987) 1.01
Age and menopause-related changes in indices of bone turnover. J Clin Endocrinol Metab (1989) 1.00
Reduced serum 1,25-(OH)2 vitamin D3 levels in prednisone-treated adolescents with systemic lupus erythematosus. Acta Paediatr Scand (1979) 1.00
Bariatric surgery, bone loss, obesity and possible mechanisms. Obes Rev (2012) 0.99
Lifestyle factors and bone density in the elderly: implications for osteoporosis prevention. J Bone Miner Res (1994) 0.99
Genetic and environmental correlations between bone formation and bone mineral density: a twin study. Bone (1998) 0.99
Interaction of genetic and environmental influences on peak bone density. Osteoporos Int (1990) 0.98
Increased formation and decreased resorption of bone in mice with elevated vitamin D receptor in mature cells of the osteoblastic lineage. FASEB J (2000) 0.98
Presence of 1,25-dihydroxyvitamin D3 receptors in established human cancer cell lines in culture. Cancer Res (1982) 0.97
Genetic and environmental contributions to the association between quantitative ultrasound and bone mineral density measurements: a twin study. J Bone Miner Res (1998) 0.96
Calcium-dependent, parathyroid hormone-independent regulation of 1,25-dihydroxyvitamin D. Am J Physiol (1980) 0.96
Genetic influences on bone turnover, bone density and fracture. Eur J Endocrinol (1995) 0.95